BIOGEN IDEC INC. BIIB

expiry = 2007-06-26...(including associated preferred stock purchase rights) at a per share purchase price not less than $47.00 per share nor greater than $53.00 per share THE OFFER, WITHDRAWAL RIGHTS AND PRORATION PERIOD WILL EXPIRE AT 12:00 MIDNIGHT NEW YORK CITY TIME ON JUNE 26, 2007 UNLESS THE OFFER IS EXTENDED. Biogen Idec Inc. is offering to: • purchase up to 56,603,773 shares of our common stock, including the associated preferred stock purchase rights, in a tender offer; and • purchase these shares at a price not...

listed = True...shares tendered at or below the selected purchase price is more than 56,603,773, we may exercise our right to amend the offer to purchase up to an additional 2% of our outstanding shares without extending the expiration date. Our common stock: • is listed and traded on The NASDAQ Global Select Market under the symbol “BIIB;” and • had a closing price of $49.21 per share on May 29, 2007, the last full trading day before we announced the offer. We urge you to obtain current market quotations for the shares. The offer is not conditioned on any minimum number of shares being tendered. The offer is, however, subject t...

mechanism = DUTCH...en Idec Inc. and ChaseMellon Shareholder Services LLC, as amended. See Sections 1 and 6. How much is Biogen Idec offering to pay? • The price range for the offer is $47.00 to $53.00 per share. We are conducting the offer through a procedure commonly called a “modified Dutch auction.” This procedure allows you to choose a price (in increments of $0.25) within this price range at which you are willing to sell your shares or tender at the purchase price determined by us pursuant to the offer. • We will look at the prices chosen by shareholders for all of the shares properly tendered. We will then select the lowest pri...

must_tender_all = True...shares conditionally tendered at or below the purchase price for which the condition was not initially satisfied, to the extent feasible, by random lot (to be eligible for purchase by random lot, shareholders whose shares are conditionally tendered must have tendered all of their shares). See Section 1. How will Biogen Idec obtain the funds to make the payment? • Assuming that the maximum number of shares is tendered in the offer and the purchase price is an amount between $47.00 and $53.00 per share, the aggregate purchase price for the shares purchased in the offer would be between approximately $2.66 billion and $3.0...

price = USD 47.0-53.0...ent, dated as of July 22, 1997, between Biogen Idec Inc. and ChaseMellon Shareholder Services LLC, as amended. See Sections 1 and 6. How much is Biogen Idec offering to pay? • The price range for the offer is $47.00 to $53.00 per share. We are conducting the offer through a procedure commonly called a “modified Dutch auction.” This procedure allows you to choose a price (in increments of $0.25) within this price range at which you are willin...

threshold = 100...3,773, we will purchase all these shares tendered at that price; • if the number of shares tendered at or below the selected price is more than 56,603,773, we will purchase shares at the selected price on a pro rata basis (disregarding fractions), except for “odd lots” (lots of fewer than 100 shares that will be purchased from the beneficial owners on a priority basis) from all shareholders who tendered shares at or below the selected price; and • if the number of shares tendered at or below the selected purchase price is more than 56,603,773, we may exercise our right to amend the offer to purchase up to an additional 2% of our out...

txn_type = TENDER_OFFEREX-99.(A)(1)(A) 2 b65594biexv99wxayx1yxay.htm EX-(A)(1)(A) OFFER TO PURCHASE DATED MAY 30, 2007 exv99wxayx1yxay Table of Contents Exhibit (a)(1)(A) BIOGEN IDEC INC. OFFER TO PURCHASE FOR CASH Up to 56,603,773 shares of its common stock (including associated preferred stock purchase rights) at a per share purchase price not less than $47.00 per share nor greater than $53.00 per share THE OFFER, WITHDRAWAL RIGHTS A...